uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
24.88
+0.37
(+1.51%)
Pre-Market: 08:38
uniQure Debt to Equity Ratio : 1.704 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.704 |
| March 31, 2026 | 3.654 |
| December 31, 2025 | 2.698 |
| September 30, 2025 | 2.324 |
| June 30, 2025 | -130.39 |
| March 31, 2025 | 15.22 |
| December 31, 2024 | -74.20 |
| September 30, 2024 | 8.855 |
| June 30, 2024 | 5.504 |
| March 31, 2024 | 3.697 |
| December 31, 2023 | 2.565 |
| September 30, 2023 | 1.942 |
| June 30, 2023 | 1.448 |
| March 31, 2023 | 0.344 |
| December 31, 2022 | 0.3002 |
| September 30, 2022 | 0.3294 |
| June 30, 2022 | 0.286 |
| March 31, 2022 | 0.248 |
| December 31, 2021 | 0.2278 |
| September 30, 2021 | 0.1812 |
| June 30, 2021 | 0.169 |
| March 31, 2021 | 0.4609 |
| December 31, 2020 | 0.2933 |
| September 30, 2020 | 0.3132 |
| June 30, 2020 | 0.268 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2461 |
| December 31, 2019 | 0.2262 |
| September 30, 2019 | 0.2045 |
| June 30, 2019 | 0.5445 |
| March 31, 2019 | 0.3996 |
| December 31, 2018 | 0.1975 |
| September 30, 2018 | 0.1036 |
| June 30, 2018 | 0.0955 |
| March 31, 2018 | 0.2076 |
| December 31, 2017 | 0.2327 |
| September 30, 2017 | 1.050 |
| June 30, 2017 | 0.7503 |
| March 31, 2017 | 0.4453 |
| December 31, 2016 | |
| September 30, 2016 | 0.2526 |
| June 30, 2016 | 0.2158 |
| March 31, 2016 | 0.1775 |
| December 31, 2015 | 0.17 |
| September 30, 2015 | 0.1557 |
| June 30, 2015 | 0.1983 |
| March 31, 2015 | 0.6177 |
| December 31, 2014 | 0.404 |
| September 30, 2014 | 0.3169 |
| June 30, 2014 | 0.2785 |
| March 31, 2014 | 0.1315 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kymera Therapeutics, Inc. | 0.0521 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Twist Bioscience Corp. | 0.21 |
| GRAIL, Inc. | 0.0359 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 985.10M |
| Total Liabilities (Quarterly) | 661.05M |
| Shareholders Equity (Quarterly) | 324.05M |
| Current Ratio | 10.01 |
| Net Debt Paydown Yield | -0.25% |